Rare diseases
Investigational molecules
Locations
Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy
CzechiaStudy on Donanemab, Florbetapir, and Flortaucipir for Patients with Early Alzheimer's Disease
CzechiaStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
CzechiaStudy on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer
AustriaStudy on Obinutuzumab and Rituximab with Chemotherapy for Adults with Newly Diagnosed CD20-Positive Acute Lymphoblastic Leukemia
PolandStudy to Evaluate Plozasiran for Adults with High Triglycerides
BulgariaStudy on BHV-7000 for Patients with Generalized Tonic-clonic Seizures in Idiopathic Generalized Epilepsy
AustriaStudy of dupilumab added to inhaled corticosteroids and long-acting beta-agonists compared to high-dose inhaled therapy in adolescents and adults with uncontrolled asthma
DenmarkStudy of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)
BelgiumStudy on the Effectiveness and Safety of Polatuzumab Vedotin, Rituximab, and CHP in Patients with Untreated Diffuse Large B-Cell Lymphoma
AustriaStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
